doi: 10.1182/blood-2008-09-181040 106 XuCSunSJohnsonTQiRZhangSZhangJet al
Moreover, dulaglutide produces greater weight loss in CNS GIPR knockout (KO) mice, and the weight loss achieved with dulaglutide + GIPR-Ab is attenuated in CNS GIPR KO mice
Some of these include flu, dry eye, cough and other lung conditions, kidney disease and Tylenol overdose
Treatment should be discontinued if inadequate response occurs: less than 5% weight loss after 6 months for Wegovy or 12 weeks for Saxenda at maintenance doses
Current clinical evidence does not support tirzepatide use during breastfeeding due to limited safety data in lactating populations and theoretical infant exposure through breast milk
The beneficial effect of this antioxidant has been documented during various cancers of breast, lung, prostate, colon and also in leukemia (Karas et al., 2000